Extensively drug-resistant mycobacterium tuberculosis (Q49350): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Micobactérias tuberculosas extensivamente resistentes a medicamentos são resistentes a pelo menos quatro dos principais medicamentos anti-TB. As micobactérias XDR-TB são resistentes aos dois medicamentos anti-TB mais poderosos, isoniazida e rifampicina, também conhecida como multirresistência a medicamentos, além da resistência a qualquer uma das fluoroquinolonas (como levofloxacina ou moxifloxacina) e a pelo menos uma das três drogas injetáveis de segunda linha (amicacina, capreomicina ou canamicina). | |||
| description / en | description / en | ||
Extensively drug-resistant tuberculous mycobacteria are resistant to at least four of the core anti-TB drugs. XDR-TB mycobacteria are resistant to the two most powerful anti-TB drugs, isoniazid and rifampicin, also known as multidrug-resistance, in addition to resistance to any of the fluoroquinolones (such as levofloxacin or moxifloxacin) and to at least one of the three injectable second-line drugs (amikacin, capreomycin or kanamycin). | |||
Revision as of 19:43, 13 August 2026
Extensively drug-resistant tuberculous mycobacteria are resistant to at least four of the core anti-TB drugs. XDR-TB mycobacteria are resistant to the two most powerful anti-TB drugs, isoniazid and rifampicin, also known as multidrug-resistance, in addition to resistance to any of the fluoroquinolones (such as levofloxacin or moxifloxacin) and to at least one of the three injectable second-line drugs (amikacin, capreomycin or kanamycin).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | MG52.02 |
||
| English | Extensively drug-resistant mycobacterium tuberculosis |
Extensively drug-resistant tuberculous mycobacteria are resistant to at least four of the core anti-TB drugs. XDR-TB mycobacteria are resistant to the two most powerful anti-TB drugs, isoniazid and rifampicin, also known as multidrug-resistance, in addition to resistance to any of the fluoroquinolones (such as levofloxacin or moxifloxacin) and to at least one of the three injectable second-line drugs (amikacin, capreomycin or kanamycin). |
